California Public Employees Retirement System Has $124.64 Million Stock Position in HCA Healthcare, Inc. $HCA

California Public Employees Retirement System cut its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 325,357 shares of the company’s stock after selling 18,695 shares during the period. California Public Employees Retirement System owned about 0.14% of HCA Healthcare worth $124,644,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Norges Bank acquired a new stake in shares of HCA Healthcare during the 2nd quarter valued at about $1,152,408,000. Price T Rowe Associates Inc. MD boosted its holdings in HCA Healthcare by 83.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after purchasing an additional 1,091,416 shares in the last quarter. Nuveen LLC acquired a new position in shares of HCA Healthcare in the 1st quarter worth approximately $569,217,000. Nordea Investment Management AB boosted its stake in HCA Healthcare by 6.8% in the 2nd quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock valued at $350,404,000 after buying an additional 59,163 shares in the last quarter. Finally, LSV Asset Management lifted its holdings in shares of HCA Healthcare by 0.4% during the second quarter. LSV Asset Management now owns 868,849 shares of the company’s stock valued at $332,856,000 after acquiring an additional 3,396 shares during the period. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This represents a 52.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Stock Down 0.3%

HCA stock opened at $486.40 on Monday. The business has a fifty day moving average of $459.97 and a 200-day moving average of $410.43. The company has a market cap of $110.99 billion, a P/E ratio of 18.80, a PEG ratio of 1.44 and a beta of 1.36. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $520.00.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. During the same period last year, the company earned $4.90 earnings per share. The company’s revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on HCA. Sanford C. Bernstein reissued a “market perform” rating and set a $417.00 price target on shares of HCA Healthcare in a report on Monday, October 27th. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 1st. Barclays raised their price target on HCA Healthcare from $445.00 to $494.00 and gave the company an “overweight” rating in a report on Monday, October 27th. Oppenheimer increased their target price on HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a report on Monday, October 27th. Finally, Wells Fargo & Company upped their price target on shares of HCA Healthcare from $412.00 to $431.00 and gave the stock an “equal weight” rating in a research report on Thursday, November 13th. Fourteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $474.53.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.